Spire Healthcare Group plc (LON:SPI) Declares Dividend Increase – GBX 2.10 Per Share

Spire Healthcare Group plc (LON:SPI) declared a dividend on Thursday, February 29th, Upcoming.Co.Uk reports. Stockholders of record on Thursday, May 23rd will be paid a dividend of GBX 2.10 ($0.03) per share on Friday, June 21st. This represents a dividend yield of 0.89%. The ex-dividend date of this dividend is Thursday, May 23rd. This is a boost from Spire Healthcare Group’s previous dividend of $0.50. The official announcement can be seen at this link.

Spire Healthcare Group Stock Performance

Shares of LON SPI opened at GBX 267 ($3.39) on Wednesday. The company has a debt-to-equity ratio of 170.37, a current ratio of 0.69 and a quick ratio of 0.74. The firm has a market cap of £1.08 billion, a price-to-earnings ratio of 3,821.43, a P/E/G ratio of 1.06 and a beta of 0.97. The stock’s fifty day moving average price is GBX 243.83 and its two-hundred day moving average price is GBX 234.66. Spire Healthcare Group has a one year low of GBX 204 ($2.59) and a one year high of GBX 269.50 ($3.43).

Analysts Set New Price Targets

A number of research analysts have issued reports on SPI shares. JPMorgan Chase & Co. restated an “overweight” rating and set a GBX 344 ($4.37) target price on shares of Spire Healthcare Group in a research report on Thursday, April 18th. Berenberg Bank increased their price target on Spire Healthcare Group from GBX 286 ($3.63) to GBX 300 ($3.81) and gave the stock a “buy” rating in a research report on Wednesday, April 17th.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.